BIOSCIENCE DEVELOPMENT, INC.
Medtech
PCR-based diagnostic assay for early detection of Borrelia burgdorferi (Lyme disease) in blood with enhanced sensitivity through targeted DNA amplification
- Grants
- $3.6M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of Molecular Diagnostic Test For Early Onset of Lyme Disease | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of Diagnostic Test for Early Multiple Sclerosis | $299,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Molecular Diagnostic Test for Early Onset of Lyme disease | $988,413 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Molecular Diagnostic Test for Early Onset of Lyme disease | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of Molecular Diagnostic Test for Early Onset of Lyme disease | $998,043 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1851 | Pragma Health Corp. | — | — |
| 1852 | PATHFLOW INC. | — | — |
| 1853 | ADAVANCE NANOLYTICS INC | — | — |
| 1854 | BIOSCIENCE DEVELOPMENT, INC. | — | — |
| 1855 | INSIGHTFIL | — | — |
| 1856 | EVORX TECHNOLOGIES, INC. | — | — |
| 1857 | PZA INNOVATION LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.